← Leaderboards
Priyamvada Rai
University Of Miami School Of Medicine
$4,728,635
Attributed
$4,981,457
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $730.4K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,981,457 · 4
By mechanism
R01$3,532,683 · 2
R25$1,380,979 · 1
P30$67,795 · 1
Top collaborators
- Claude-Henry Volmar2 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Scott Whittemore$15,549,718
- Bradley J Goldstein$6,362,477
- Seble G Kassaye$24,111,544
- Anandi Nayan Sheth$14,479,163
- Aadia Rana$9,606,090
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectCellsMolecularOxidation-ReductionSignal TransductionTumorMediatingProteinsResponseScreeningData SetOncogenicPre-ClinicalPathway InteractionsBiologyResistanceStressLaboratoriesIn VivoPreventOverexpressionOxidative StressMalignant NeoplasmsMaintenance
Grant awards (20)
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$212,386
R25 · FY2025 · CA · contact PI
Tumor Biology Research Program$36,630
P30 · FY2025 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$333,575
R01 · FY2024 · CA · contact PI
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$293,259
R25 · FY2024 · CA · contact PI
Tumor Biology Research Program$31,165
P30 · FY2024 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$344,109
R01 · FY2023 · CA · contact PI
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$273,687
R25 · FY2023 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$73,304
R01 · FY2023 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$344,109
R01 · FY2022 · CA · contact PI
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$299,363
R25 · FY2022 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$75,431
R01 · FY2022 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$351,131
R01 · FY2021 · CA · contact PI
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$302,284
R25 · FY2021 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$76,970
R01 · FY2021 · CA · contact PI
Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression$351,131
R01 · FY2020 · CA · contact PI
MutT Homolog 1 as a Novel Mediator of RAS Oncogene-Induced Pro-Malignant Pathways$318,513
R01 · FY2017 · CA · contact PI
MutT Homolog 1 as a Novel Mediator of RAS Oncogene-Induced Pro-Malignant Pathways$318,513
R01 · FY2016 · CA · contact PI
MutT Homolog 1 as a Novel Mediator of RAS Oncogene-Induced Pro-Malignant Pathways$318,513
R01 · FY2015 · CA · contact PI
MutT Homolog 1 as a Novel Mediator of RAS Oncogene-Induced Pro-Malignant Pathways$308,958
R01 · FY2014 · CA · contact PI
MutT Homolog 1 as a Novel Mediator of RAS Oncogene-Induced Pro-Malignant Pathways$318,426
R01 · FY2013 · CA · contact PI